Designing Trials to Consider the Full Spectrum of Patient Outcomes
ACT: How is clinical trial design and analysis changing in response to more comprehensive evaluation methods (methods that…
Beyond the Ordinary Beyond the Obvious
ACT: How is clinical trial design and analysis changing in response to more comprehensive evaluation methods (methods that…
Image credit: Sweettymojidesign | stock.adobe.com Two-year data from the Phase III BE MOBILE 1, BE MOBILE 2, and…
ACT: How can we transform cancer care through more patient-centered research and treatment analysis? Buyse: Just building on…
Image credit: Crystal light | stock.adobe.com Two-year interim data from the Phase III ASSURE trial (NCT03301506) show sustained…
ACT: What are some of the unique challenges facing oncology trials today? Buyse: Well, I think there are…
Applied Clinical Trials June 2024 Issue (PDF) Sustainability: More than Meets the Eye Status Check: Science & Sustainability…
Image Credit: © putilov_denis – stock.adobe.com Systematic reviews are a key element of clinical research. While these reviews…
Image Credit: © Murrstock – stock.adobe.com We presented an initial review of quality tolerance limit (QTL) adoption trends…
Image credit: Dr_Microbe | stock.adobe.com Elahere (mirvetuximab soravtansine; AbbVie) achieved both the primary and secondary endpoints of the…
Image Credit: © Supapeach – stock.adobe.com A few points to review before we reach the heart of this…